Latest / Research To Practice | Oncology Videos
Multiple Myeloma | BCMA-Directed Therapy in Multiple Myeloma: Expert Opinions and Patient Perspectives — Part 2
Featuring perspectives from Dr S Vincent Rajkumar, including the following topics:
Introduction: Requiem for Belantamab Mafodotin? Dawn of a New Era (0:00)
Case: A man in his early 70s with multiregimen-refractory multiple myeloma (MM) receives idecabtagene vicleucel with Grade 1 cytokine release syndrome and persistent cytopenias — Jesús G Berdeja, MD (16:12)
Case: A man in his mid 60s with multiregimen-refractory MM receives idecabtagene vicleucel with a 20-month response — Dr Berdeja (25:19)
Case: A man in his late 50s with multiregimen-refractory MM received idecabtagene vicleucel in 2020…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.